핵의학

본문글자크기
  • [Clin Nucl Med.] Initial Versus Follow-up Sequential Myocardial 123I-MIBG Scintigraphy to Discriminate Parkinson Disease From Atypical Parkinsonian Syndromes.

    가톨릭의대 / 류동우, 이광수*

  • 출처
    Clin Nucl Med.
  • 등재일
    2019 Apr
  • 저널이슈번호
    44(4):282-288. doi: 10.1097/RLU.0000000000002424.
  • 내용

    바로가기  >

    Abstract
    PURPOSE:
    Previous single-center or meta-analysis studies analyzed myocardial I-metaiodobenzylguanidine (I-MIBG) scintigraphy in a single image session and demonstrated low sensitivity and high specificity for discriminating Parkinson disease (PD) from atypical Parkinsonian syndromes (APS). This study aimed to assess diagnostic ability of myocardial I-MIBG scintigraphy at 2 phases to discriminate PD from APS.

    PATIENTS AND METHODS:
    This hospital-based prospective study enrolled 162 PD and 26 APS patients who underwent 2 sequential I-MIBG scintigraphy evaluations. Patients were stratified into normal and decreased I-MIBG groups according to early and delayed heart-to-mediastinum (H/M) ratios. Patients with PD and normal I-MIBG uptake (initial delayed H/M ratio, ≥1.78) were considered scans without evidence of cardiac norepinephrine deficit (SWEND). Early and delayed H/M ratios on the initial and 2-year follow-up scintigraphs were studied. The diagnostic sensitivity and specificity were calculated from these confusion matrices and were analyzed according to receiver-operating characteristic curve analysis. A repeated-measures general linear model was used to investigate differences among groups over time in H/M ratio changes and washout rates.

    RESULTS:
    Follow-up I-MIBG scintigraphy analysis had a higher diagnostic sensitivity (89.5%) than the initial imaging (72.2%). The improved sensitivity was associated with a steeper decrease in H/M ratio in the SWEND group than in the APS group.

    CONCLUSIONS:
    Follow-up I-MIBG scintigraphy can identify cardiac sympathetic denervation and its progression in patients with PD and may be effective in discriminating PD from APS. A later decrease in myocardial I-MIBG uptake in the group with SWEND meets the Braak staging threshold hypothesis for synucleinopathy.

     


    Author information

    Ryu DW1, Kim JS1, Lee JE1, Oh YS1, Yoo SW1, Yoo IR2, Lee KS1.
    1
    From the Departments of Neurology and.
    2
    Nuclear Medicine, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea.

  • 덧글달기
    덧글달기
       IP : 3.21.248.119

    등록